Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

F. Zeka, A. Decock, A. Van Goethem, K. Vanderheyden, F. Demuynck, T. Lammens, HH. Helsmoortel, J. Vermeulen, R. Noguera, AP. Berbegall, V. Combaret, G. Schleiermacher, G. Laureys, A. Schramm, JH. Schulte, S. Rahmann, J. Bienertová-Vašků, P....

. 2018 ; 3 (23) : . [pub] 20181206

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045099

In this study, the circulating miRNome from diagnostic neuroblastoma serum was assessed for identification of noninvasive biomarkers with potential in monitoring metastatic disease. After determining the circulating neuroblastoma miRNome, 743 miRNAs were screened in 2 independent cohorts of 131 and 54 patients. Evaluation of serum miRNA variance in a model testing for tumor stage, MYCN status, age at diagnosis, and overall survival revealed tumor stage as the most significant factor impacting miRNA abundance in neuroblastoma serum. Differential abundance analysis between patients with metastatic and localized disease revealed 9 miRNAs strongly associated with metastatic stage 4 disease in both patient cohorts. Increasing levels of these miRNAs were also observed in serum from xenografted mice bearing human neuroblastoma tumors. Moreover, murine serum miRNA levels were strongly associated with tumor volume. These findings were validated in longitudinal serum samples from metastatic neuroblastoma patients, where the 9 miRNAs were associated with disease burden and treatment response.

Cancer Research Institute Ghent Ghent University Ghent Belgium Department of Pediatric Hematology Oncology and Stem Cell Transplantation Ghent University Hospital Ghent Belgium

Center for Medical Genetics Department of Biomolecular Medicine and

Center for Medical Genetics Department of Biomolecular Medicine and Cancer Research Institute Ghent Ghent University Ghent Belgium

Department of Paediatric Oncology Institut Curie Paris France

Department of Pathology Medical School University of Valencia CIBERONC Madrid Spain

Department of Pathology Medical School University of Valencia CIBERONC Madrid Spain INCLIVA Biomedical Research Institute Valencia Spain

Department of Pediatric Oncology University Hospital Brno Brno Czech Republic

Department of Pediatrics Section of Hematology Oncology Texas Children's Cancer Center Baylor College of Medicine Houston Texas USA

Division of Oncology The Children's Hospital of Philadelphia Philadelphia USA

Genome Informatics Institute of Human Genetics University Hospital Essen University of Duisburg Essen Essen Germany

Laboratoire de Recherche Translationnelle Centre Léon Bérard Lyon France

Molecular Oncology West German Cancer Center University Hospital Essen University of Duisburg Essen Essen Germany

Molecular Oncology West German Cancer Center University Hospital Essen University of Duisburg Essen Essen Germany Pediatric Oncology and Hematology Charité University Medicine Berlin Germany German Cancer Research Center Heidelberg Germany

Pediatric Hematology Oncology Schneider Children's Medical Center of Israel Tel Aviv Israel

Pediatric Oncology and Hematology University Children's Hospital of Cologne Medical Faculty and

Pediatric Oncology and Hematology University Children's Hospital of Cologne Medical Faculty and Center for Molecular Medicine Cologne University of Cologne Cologne Germany

Pédiatrie Hôpital de Jolimont Haine Saint Paul Belgium

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045099
003      
CZ-PrNML
005      
20200114153240.0
007      
ta
008      
200109s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1172/jci.insight.97021 $2 doi
035    __
$a (PubMed)30518699
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zeka, Fjoralba $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
245    10
$a Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients / $c F. Zeka, A. Decock, A. Van Goethem, K. Vanderheyden, F. Demuynck, T. Lammens, HH. Helsmoortel, J. Vermeulen, R. Noguera, AP. Berbegall, V. Combaret, G. Schleiermacher, G. Laureys, A. Schramm, JH. Schulte, S. Rahmann, J. Bienertová-Vašků, P. Mazánek, M. Jeison, S. Ash, MD. Hogarty, M. Moreno-Smith, E. Barbieri, J. Shohet, F. Berthold, T. Van Maerken, F. Speleman, M. Fischer, K. De Preter, P. Mestdagh, J. Vandesompele,
520    9_
$a In this study, the circulating miRNome from diagnostic neuroblastoma serum was assessed for identification of noninvasive biomarkers with potential in monitoring metastatic disease. After determining the circulating neuroblastoma miRNome, 743 miRNAs were screened in 2 independent cohorts of 131 and 54 patients. Evaluation of serum miRNA variance in a model testing for tumor stage, MYCN status, age at diagnosis, and overall survival revealed tumor stage as the most significant factor impacting miRNA abundance in neuroblastoma serum. Differential abundance analysis between patients with metastatic and localized disease revealed 9 miRNAs strongly associated with metastatic stage 4 disease in both patient cohorts. Increasing levels of these miRNAs were also observed in serum from xenografted mice bearing human neuroblastoma tumors. Moreover, murine serum miRNA levels were strongly associated with tumor volume. These findings were validated in longitudinal serum samples from metastatic neuroblastoma patients, where the 9 miRNAs were associated with disease burden and treatment response.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové biomarkery $x krev $7 D014408
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a cirkulující mikroRNA $x krev $7 D000074166
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a mikro RNA $x krev $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a metastázy nádorů $x diagnóza $7 D009362
650    _2
$a staging nádorů $7 D009367
650    _2
$a neuroblastom $x krev $x diagnóza $7 D009447
650    _2
$a transplantace heterologní $7 D014183
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Decock, Anneleen $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
700    1_
$a Van Goethem, Alan $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
700    1_
$a Vanderheyden, Katrien $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
700    1_
$a Demuynck, Fleur $u Center for Medical Genetics, Department of Biomolecular Medicine, and.
700    1_
$a Lammens, Tim $u Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium. Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
700    1_
$a Helsmoortel, Hetty H $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
700    1_
$a Vermeulen, Joëlle $u Pédiatrie, Hôpital de Jolimont, Haine-Saint-Paul, Belgium.
700    1_
$a Noguera, Rosa $u Department of Pathology, Medical School, University of Valencia/CIBERONC Madrid, Spain.
700    1_
$a Berbegall, Ana P $u Department of Pathology, Medical School, University of Valencia/CIBERONC Madrid, Spain. INCLIVA Biomedical Research Institute, Valencia, Spain.
700    1_
$a Combaret, Valérie $u Laboratoire de Recherche Translationnelle, Centre Léon-Bérard, Lyon, France.
700    1_
$a Schleiermacher, Gudrun $u Department of Paediatric Oncology, Institut Curie, Paris, France.
700    1_
$a Laureys, Geneviève $u Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium. Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
700    1_
$a Schramm, Alexander $u Molecular Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
700    1_
$a Schulte, Johannes H $u Molecular Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Pediatric Oncology and Hematology, Charité University Medicine, Berlin, Germany. German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
700    1_
$a Rahmann, Sven $u Genome Informatics, Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
700    1_
$a Bienertová-Vašků, Julie $u Department of Pediatric Oncology, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Mazánek, Pavel $u Department of Pediatric Oncology, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Jeison, Marta $u Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Tel Aviv, Israel.
700    1_
$a Ash, Shifra $u Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Tel Aviv, Israel.
700    1_
$a Hogarty, Michael D $u Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, USA.
700    1_
$a Moreno-Smith, Mirthala $u Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
700    1_
$a Barbieri, Eveline $u Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
700    1_
$a Shohet, Jason $u Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
700    1_
$a Berthold, Frank $u Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, and.
700    1_
$a Van Maerken, Tom $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
700    1_
$a Speleman, Frank $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
700    1_
$a Fischer, Matthias $u Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, and. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
700    1_
$a De Preter, Katleen $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
700    1_
$a Mestdagh, Pieter $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
700    1_
$a Vandesompele, Jo $u Center for Medical Genetics, Department of Biomolecular Medicine, and. Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
773    0_
$w MED00194017 $t JCI insight $x 2379-3708 $g Roč. 3, č. 23 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30518699 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200114153613 $b ABA008
999    __
$a ok $b bmc $g 1483368 $s 1083772
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 3 $c 23 $e 20181206 $i 2379-3708 $m JCI insight $n JCI Insight $x MED00194017
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace